- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1897-4287
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
CHEK2 mutations as markers for high risk of breast cancer ; volume:10 ; number:3 ; day:20 ; month:4 ; year:2012 ; pages:1 ; date:12.2012
Hereditary cancer in clinical practice ; 10, Heft 3 (20.4.2012), 1, 12.2012
- Urheber
-
Cybulski, Cezary
- Beteiligte Personen und Organisationen
-
Wokołorczyk, Dominika
Jakubowska, Anna
Huzarski, Tomasz
Byrski, Tomasz
Gronwald, Jacek
De̜bniak, Tadeusz
Gorski, Bohdan
Blecharz, P.
Narod, S A.
Lubinski, Jan
SpringerLink (Online service)
- DOI
-
10.1186/1897-4287-10-S3-A4
- URN
-
urn:nbn:de:1111-2016073118195
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:59 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Cybulski, Cezary
- Wokołorczyk, Dominika
- Jakubowska, Anna
- Huzarski, Tomasz
- Byrski, Tomasz
- Gronwald, Jacek
- De̜bniak, Tadeusz
- Gorski, Bohdan
- Blecharz, P.
- Narod, S A.
- Lubinski, Jan
- SpringerLink (Online service)
Ähnliche Objekte (12)
Prospective clinical trials on correlations between macro-/ microelements and vitamins and cancer risk
Folic acid and breast cancer risk
A common missense variant in BRCA2 predisposes to early onset breast cancer
HOXB13 mutations and prostate cancer in Poland
Cisplatin in breast cancer treatment in BRCA1 carriers
Prostate cancer screening based on genotyping for high risk founder alleles
The potential role of miRNAs in therapy of breast and ovarian cancers associated with BRCA1 mutation
Hereditary Cancer in Clinical Practice transfers to BioMed Central
Germline deletions in the EPCAM gene as a cause of Lynch syndrome – literature review
Arsenic (As) and breast cancer risk
BRCA1 founder mutations do not contribute to increased risk of gastric cancer in the Polish population
Thank you to all our manuscript reviewers in 2014
Prospective clinical trials on correlations between macro-/ microelements and vitamins and cancer risk
Folic acid and breast cancer risk
A common missense variant in BRCA2 predisposes to early onset breast cancer
HOXB13 mutations and prostate cancer in Poland
Cisplatin in breast cancer treatment in BRCA1 carriers
Prostate cancer screening based on genotyping for high risk founder alleles
The potential role of miRNAs in therapy of breast and ovarian cancers associated with BRCA1 mutation
Hereditary Cancer in Clinical Practice transfers to BioMed Central
Germline deletions in the EPCAM gene as a cause of Lynch syndrome – literature review
Arsenic (As) and breast cancer risk
BRCA1 founder mutations do not contribute to increased risk of gastric cancer in the Polish population
Thank you to all our manuscript reviewers in 2014
Prospective clinical trials on correlations between macro-/ microelements and vitamins and cancer risk
Folic acid and breast cancer risk
A common missense variant in BRCA2 predisposes to early onset breast cancer
HOXB13 mutations and prostate cancer in Poland
Cisplatin in breast cancer treatment in BRCA1 carriers
Prostate cancer screening based on genotyping for high risk founder alleles
The potential role of miRNAs in therapy of breast and ovarian cancers associated with BRCA1 mutation
Hereditary Cancer in Clinical Practice transfers to BioMed Central
Germline deletions in the EPCAM gene as a cause of Lynch syndrome – literature review
Arsenic (As) and breast cancer risk
BRCA1 founder mutations do not contribute to increased risk of gastric cancer in the Polish population